




Searching News Database: lidocaine
HSMN NewsFeed - 20 Sep 2023
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
HSMN NewsFeed - 8 Nov 2022
IceCure's ProSense(R) Achieves Significant Milestone in Medicare Coverage of Breast Cancer Procedures
IceCure's ProSense(R) Achieves Significant Milestone in Medicare Coverage of Breast Cancer Procedures
HSMN NewsFeed - 1 Feb 2021
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
Galderma Receives FDA Approval for Restylane(R) Defyne for Chin Augmentation
HSMN NewsFeed - 28 May 2020
Smith & Nephew announces US launch of the revolutionary Tula(R) System for placement of ear tubes
Smith & Nephew announces US launch of the revolutionary Tula(R) System for placement of ear tubes
HSMN NewsFeed - 18 Dec 2019
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
HSMN NewsFeed - 3 Sep 2019
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
Allergan Receives FDA Approval of Juvéderm VOLUMA(R) XC For Mid-Face Injection Via Cannula
HSMN NewsFeed - 29 Nov 2018
Nuvo Pharmaceuticals(TM) Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals
Nuvo Pharmaceuticals(TM) Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals
HSMN NewsFeed - 5 Nov 2018
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
Galderma Announces FDA Approval of Restylane(R) Lyft For Midface Injection via Cannula
HSMN NewsFeed - 29 Aug 2017
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
HSMN NewsFeed - 18 Jul 2017
Fagron, Inc. Announces Launch Of LETS GEL KIT(TM) for Rapid Topical Anesthesia
Fagron, Inc. Announces Launch Of LETS GEL KIT(TM) for Rapid Topical Anesthesia
HSMN NewsFeed - 15 May 2017
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
Nuvo Pharmaceuticals(TM) Inc. Announces Topline Results from European Ankle Sprain Study with Pennsaid(R) 2%
HSMN NewsFeed - 2 Jun 2016
Juniper Pharmaceuticals Announces Planned Retirement of CEO Frank Condella
Juniper Pharmaceuticals Announces Planned Retirement of CEO Frank Condella
HSMN NewsFeed - 4 Apr 2016
Nuvo Pharmaceuticals(TM) Inc. Announces Appointment of Vice President, Business Development
Nuvo Pharmaceuticals(TM) Inc. Announces Appointment of Vice President, Business Development
HSMN NewsFeed - 15 Oct 2015
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula
HSMN NewsFeed - 8 Jan 2013
Absorption Pharmaceuticals Names Laurence A. Levine, MD As The Company's Chief Medical Officer
Absorption Pharmaceuticals Names Laurence A. Levine, MD As The Company's Chief Medical Officer
HSMN NewsFeed - 9 Mar 2011
Significant Reduction in Pain With the Mynx Vascular Closure Device Versus Angio-Seal Device
Significant Reduction in Pain With the Mynx Vascular Closure Device Versus Angio-Seal Device
HSMN NewsFeed - 9 Jan 2009
Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
HSMN NewsFeed - 3 Sep 2008
Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
HSMN NewsFeed - 8 Jul 2008
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
Anika Therapeutics Announces Exclusive U.S. Distribution Agreement for Elevess Injectable Dermal Filler
HSMN NewsFeed - 30 Jun 2008
Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
HSMN NewsFeed - 3 Jun 2008
New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
HSMN NewsFeed - 7 Apr 2008
New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe
New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe
HSMN NewsFeed - 7 Mar 2008
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
HSMN NewsFeed - 6 Mar 2008
Onset Therapeutics Announces Launch of Anestafoam(TM), a Novel Topical Anesthetic Foam
Onset Therapeutics Announces Launch of Anestafoam(TM), a Novel Topical Anesthetic Foam
HSMN NewsFeed - 30 Jan 2008
Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
Anesiva Announces Hiring of Sales Force for FDA-Approved Product Zingo(TM)
HSMN NewsFeed - 20 Nov 2007
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
Anika Therapeutics and Galderma Agree to Terminate License, Development and Supply Agreements
HSMN NewsFeed - 12 Oct 2007
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
HSMN NewsFeed - 25 Jul 2007
A.T.S. Pharmaceuticals, A division of Auriga Laboratories Launches Xyralid(TM) LP Lotion
A.T.S. Pharmaceuticals, A division of Auriga Laboratories Launches Xyralid(TM) LP Lotion
HSMN NewsFeed - 19 Apr 2007
ZARS Announces First European Marketing Approval and License Agreement With EUSA Pharma for Rapydan(R)
ZARS Announces First European Marketing Approval and License Agreement With EUSA Pharma for Rapydan(R)
HSMN NewsFeed - 19 Mar 2007
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
New Phase IV Clinical Study Indicates LidoSite(R) Provides Rheumatology Patients Superior Pain Relief
HSMN NewsFeed - 17 Jan 2007
Endo Pharmaceuticals Receives Subpoena From U.S. Department of Health and Human Services
Endo Pharmaceuticals Receives Subpoena From U.S. Department of Health and Human Services
HSMN NewsFeed - 21 Dec 2006
Anika Therapeutics Receives FDA Approval for Its Cosmetic Tissue Augmentation Product
Anika Therapeutics Receives FDA Approval for Its Cosmetic Tissue Augmentation Product
HSMN NewsFeed - 19 Dec 2006
Endo Pharmaceuticals Submits Citizen Petition to FDA Regarding Lidoderm(R)
Endo Pharmaceuticals Submits Citizen Petition to FDA Regarding Lidoderm(R)
HSMN NewsFeed - 6 Jul 2006
ZARS Pharma Announces FDA Approval of a Topical Local Anesthetic Peel (Lidocaine and Tetracaine) 7%/7%
ZARS Pharma Announces FDA Approval of a Topical Local Anesthetic Peel (Lidocaine and Tetracaine) 7%/7%
HSMN NewsFeed - 28 Jun 2006
Adolor Corporation Appoints Scott T. Megaffin as Vice President, Marketing
Adolor Corporation Appoints Scott T. Megaffin as Vice President, Marketing
HSMN NewsFeed - 31 May 2006
Adolor's Complete Response to Approvable Letter for Entereg(R) (Alvimopan) in POI Accepted for Review by FDA
Adolor's Complete Response to Approvable Letter for Entereg(R) (Alvimopan) in POI Accepted for Review by FDA
HSMN NewsFeed - 9 May 2006
Sontra Medical Introduces Generation 2.0 SonoPrep(R) Skin Permeation Device
Sontra Medical Introduces Generation 2.0 SonoPrep(R) Skin Permeation Device
HSMN NewsFeed - 4 May 2006
GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
Additional items found! 82

Members Archive contains
82 additional stories matching:
lidocaine
(Password required)
lidocaine
(Password required)